UM  > 中華醫藥研究院
Anti-cancer effects of triterpenoids isolated form Alismatis Rhizoma on HepG2 cells
Xu,Wen1; Li,Ting2; Huang,Ming-qing1; Chen,Xiu-ping2; Lu,Jin-jian2
2013
Source PublicationACTA PHARMACOLOGICA SINICA
ISSN1671-4083
Volume34Pages:16-17
KeywordAlismatis Rhizome Triterpenoid Alisol b Cancer Structure-activity Relationship
Indexed BySCI
Language英语
WOS Research AreaChemistry ; Pharmacology & Pharmacy
WOS SubjectChemistry, Multidisciplinary ; Pharmacology & Pharmac
WOS IDWOS:000322051500072
Fulltext Access
Citation statistics
Cited Times [WOS]:2   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionInstitute of Chinese Medical Sciences
Corresponding AuthorLu,Jin-jian
Affiliation1.Fujian Univ Tradit Chinese Med, Coll Pharm, Fuzhou 350108, Peoples R China
2.Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macao, Peoples R China
Corresponding Author AffilicationUniversity of Macau
Recommended Citation
GB/T 7714
Xu,Wen,Li,Ting,Huang,Ming-qing,et al. Anti-cancer effects of triterpenoids isolated form Alismatis Rhizoma on HepG2 cells[J]. ACTA PHARMACOLOGICA SINICA,2013,34:16-17.
APA Xu,Wen,Li,Ting,Huang,Ming-qing,Chen,Xiu-ping,&Lu,Jin-jian.(2013).Anti-cancer effects of triterpenoids isolated form Alismatis Rhizoma on HepG2 cells.ACTA PHARMACOLOGICA SINICA,34,16-17.
MLA Xu,Wen,et al."Anti-cancer effects of triterpenoids isolated form Alismatis Rhizoma on HepG2 cells".ACTA PHARMACOLOGICA SINICA 34(2013):16-17.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Xu,Wen]'s Articles
[Li,Ting]'s Articles
[Huang,Ming-qing]'s Articles
Baidu academic
Similar articles in Baidu academic
[Xu,Wen]'s Articles
[Li,Ting]'s Articles
[Huang,Ming-qing]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Xu,Wen]'s Articles
[Li,Ting]'s Articles
[Huang,Ming-qing]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.